Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy

被引:0
|
作者
Richard J. Marszalek
R. John Solaro
Beata M. Wolska
机构
[1] University of Illinois at Chicago,Department of Physiology and Biophysics and the Center for Cardiovascular Research
[2] University of Illinois at Chicago,College of Medicine
[3] University of Illinois at Chicago,Department of Physiology and Biophysics (M/C 901), College of Medicine
[4] University of Illinois at Chicago,Department of Medicine, Division of Cardiology, College of Medicine
来源
Pflügers Archiv - European Journal of Physiology | 2019年 / 471卷
关键词
Hypertrophic cardiomyopathy; Microvascular; Ischemia; Pathogenesis; Energetics;
D O I
暂无
中图分类号
学科分类号
摘要
Alterations in the coronary vascular system are likely associated with a mismatch between energy demand and energy supply and critical in triggering the cascade of events that leads to symptomatic hypertrophic cardiomyopathy. Targeting the early events, particularly vascular remodeling, may be a key approach to developing effective treatments. Improvement in our understanding of hypertrophic cardiomyopathy began with the results of early biophysical studies, proceeded to genetic analyses pinpointing the mutational origin, and now pertains to imaging of the metabolic and flow-related consequences of such mutations. Microvascular dysfunction has been an ongoing hot topic in the imaging of genetic cardiomyopathies marked by its histologically significant remodeling and has proven to be a powerful asset in determining prognosis for these patients as well as enlightening scientists on a potential pathophysiological cascade that may begin early during the developmental process. Here, we discuss questions that continue to remain on the mechanistic processes leading to microvascular dysfunction, its correlation to the morphological changes in the vessels, and its contribution to disease progression.
引用
收藏
页码:769 / 780
页数:11
相关论文
共 50 条
  • [1] Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy
    Marszalek, Richard J.
    Solaro, R. John
    Wolska, Beata M.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2019, 471 (05): : 769 - 780
  • [2] CORONARY ARTERIAL MAPPING IN HYPERTROPHIC CARDIOMYOPATHY
    UPPAL, SC
    BUIS, B
    VARNAUSKAS, E
    CARDIOLOGY, 1975, 60 (03) : 173 - 184
  • [3] Pathophysiology of hypertrophic cardiomyopathy
    Östman-Smith, I
    Wettrell, G
    LANCET, 2000, 355 (9207): : 928 - 928
  • [4] Pathophysiology and treatment of hypertrophic cardiomyopathy
    Sherrid, Mark V.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2006, 49 (02) : 123 - 151
  • [5] Hypertrophic cardiomyopathy: Presentation and pathophysiology
    Lerakis, S
    Sheahan, RG
    Stouffer, GA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (05): : 324 - 329
  • [6] Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact
    Aguiar Rosa, Silvia
    Rocha Lopes, Luis
    Fiarresga, Antonio
    Ferreira, Rui Cruz
    Mota Carmo, Miguel
    MICROCIRCULATION, 2021, 28 (01)
  • [7] Hypertrophic cardiomyopathy - Pathophysiology, diagnosis, and treatment
    Popjes, ED
    Sutton, MS
    GERIATRICS, 2003, 58 (03) : 41 - 46
  • [8] GENETICS, PATHOPHYSIOLOGY, AND PROGNOSIS OF HYPERTROPHIC CARDIOMYOPATHY
    LUBBERSKLARE, E
    WATKINS, HC
    MCKENNA, WJ
    CURRENT OPINION IN CARDIOLOGY, 1991, 6 (03) : 383 - 388
  • [9] OBSTRUCTION IS UNIMPORTANT IN THE PATHOPHYSIOLOGY OF HYPERTROPHIC CARDIOMYOPATHY
    CRILEY, JM
    SIEGEL, RJ
    POSTGRADUATE MEDICAL JOURNAL, 1986, 62 (728) : 515 - 529
  • [10] Apical hypertrophic cardiomyopathy: pathophysiology, diagnosis and management
    Jiangtao Li
    Jing Fang
    Yani Liu
    Xiang Wei
    Clinical Research in Cardiology, 2024, 113 : 680 - 693